Location: Home
  • search
  • go
  • Relate News
  • 1/8/2026Hengrui Wins China Approval for Retlirafusp Alfa
  • 1/8/2026China Revises Drug Administration Law Implementation Rules to Boost In...
  • 1/8/2026China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...
  • 1/8/2026Luye's Ruoxinlin NDA Accepted in China for Anxiety Disorder Treatment
  • 1/8/2026Hansoh Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
  • 1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC
  • 1/8/2026Chinese Drug Makers Hit Record US$136B in Global Out-Licensing Deals i...
  • 1/8/2026Asia Emerges as the New Epicenter of Global Biopharma Innovation: McKi...
  • 1/7/2026Epigenic Advances FIC Epigenetic HBV Therapy With U.S. IND Clearance
  • 1/7/2026Structure Thera Secures $100M Upfront in Roche and Genentech Patent Li...
  • 1/7/2026GenHouse Pharma Advances MAT2A Inhibitor GH31 With China Trial Approva...
  • 1/7/2026GenEditBio Secures FDA IND Clearance for FIC In Vivo Genome Editing Ey...
  • 1/7/2026Shanghai ArkBio Secures China Approval for Aizhida in ADHD
  • 1/7/2026NMPA Issues Announcement on Strengthening Oversight of Contract Drug M...
  • 1/7/2026China's National Health Literacy Level Reaches 33.69% in 2025
  • 1/7/2026Anlong Secures ~CNY 100M in Series B+ Financing and Signs Major Intern...
  • 1/7/2026Wiseheart Medval Raises Over CNY 100M in Series A Financing
  • 1/7/2026ImmuneOnco and Axion Terminate Clinical Development of IMM2510/AXN-251...
  • 1/7/2026ReviR Secures China CTN Clearance for FIC CMT Drug Candidate RTX-117
  • 1/7/2026Sanofi's Redemplo Wins China Approval for Rare Lipid Disorder FCS
  • 1/7/2026Zai Lab Secures Second China Approval for Augtyro
  • 1/7/2026China Conditionally Approves BeiGene's Sonrotoclax
  • 1/7/2026NovaBridge Reports Encouraging Early Data for Givastomig Combo
  • 1/6/2026Earendil Labs and Sanofi Forge Multibillion-Dollar Alliance in Autoimm...
  • 1/6/2026Merck's First-in-Class PAH Therapy Winrevair Secures China Approval
  • 1/6/2026Ascletis Secures U.S. FDA IND Clearance for Phase II Study of ASC30
  • 1/6/2026Insilico Medicine Signs $888 Million Oncology Drug Discovery Alliance ...
  • 1/6/2026China Solicits Comments on 102nd Batch of Reference Formulations for C...
  • 1/6/2026NHSA Seeks Public Input on Draft Guidelines for Real-World Value Asses...
  • 1/6/2026China Biopharma Approvals Surge in December as NMPA Clears Wave of Nov...
  • Page:5/814 Total number of articles:24393: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group